Divison of Nephrology, Medical University of South Carolina , Charleston, South Carolina.
Division of Cardiology, Medical University of South Carolina, Ralph H. Johnson Veterans Affairs Medical Center , Charleston, South Carolina.
Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F210-F218. doi: 10.1152/ajprenal.00389.2017. Epub 2017 Oct 11.
The intrarenal renin angiotensin system (RAS) is activated in polycystic kidney disease. We have recently shown in the Pkd1 mouse that Gen 2 antisense oligonucleotide (ASO), which suppresses angiotensinogen (Agt) synthesis, is efficacious in slowing kidney cyst formation compared with lisinopril. The aim of this current study was to determine 1) if unilateral nephrectomy accelerates cystogenesis in Pkd1 mice (as previously shown in cilia knockout mice) and 2) whether Agt ASO can slow the progression in this accelerated cystic mouse model. Adult Pkd1 conditional floxed allele mice expressing cre were administered tamoxifen, resulting in global knockout of Pkd1. Three weeks after tamoxifen injection, mice underwent left unilateral nephrectomy. Mice were then treated with Agt ASO (75 mg/kg per week) or aliskiren (20 mg/kg per day)+Agt ASO or control for 8 wk. Unilateral nephrectomy accelerated kidney cyst formation compared with nonnephrectomized mice. Both Agt ASO and Aliskiren+Agt ASO treatments significantly reduced plasma and urinary Agt levels. Blood pressure was lowest in Aliskiren+Agt ASO mice among all treatment groups, and the control group had the highest blood pressure. All mice developed significant kidney cysts at 8 wk after nephrectomy, but Agt ASO and Aliskiren+Agt ASO groups had fewer kidney cysts than controls. Renal pAkt, pS6 levels, and apoptosis were significantly suppressed in those receiving Agt ASO compared with controls. These results indicate that suppressing Agt using an ASO slowed the progression of accelerated cystic kidney disease induced by unilateral nephrectomy in Pkd1 mice by suppressing intrarenal RAS, mammalian target of rapamycin pathway, and cell proliferation.
肾内肾素血管紧张素系统 (RAS) 在多囊肾病中被激活。我们最近在 Pkd1 小鼠中表明,与赖诺普利相比,抑制血管紧张素原 (Agt) 合成的 Gen 2 反义寡核苷酸 (ASO) 在减缓肾脏囊肿形成方面更有效。本研究的目的是确定 1) 单侧肾切除术是否会加速 Pkd1 小鼠的囊肿形成(如先前在纤毛缺失小鼠中所示),以及 2) Agt ASO 是否可以减缓这种加速囊性小鼠模型的进展。表达 cre 的成年 Pkd1 条件性 floxed 等位基因小鼠给予他莫昔芬,导致 Pkd1 的全局敲除。在他莫昔芬注射 3 周后,小鼠接受单侧肾切除术。然后,用 Agt ASO(75mg/kg/周)或阿利克仑+Agt ASO 或对照治疗 8 周。单侧肾切除术加速了肾脏囊肿的形成,与未行肾切除术的小鼠相比。Agt ASO 和 Aliskiren+Agt ASO 治疗均显著降低了血浆和尿液中的 Agt 水平。在所有治疗组中,阿利克仑+Agt ASO 组的血压最低,对照组的血压最高。所有小鼠在肾切除后 8 周均出现明显的肾脏囊肿,但 Agt ASO 和 Aliskiren+Agt ASO 组的肾脏囊肿少于对照组。与对照组相比,接受 Agt ASO 治疗的小鼠肾脏中的 pAkt、pS6 水平和细胞凋亡均显著受到抑制。这些结果表明,使用 ASO 抑制 Agt 可通过抑制肾内 RAS、雷帕霉素靶蛋白通路和细胞增殖来减缓单侧肾切除诱导的 Pkd1 小鼠加速性囊性肾病的进展。